|
|
(122 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
Zeile 1: |
Zeile 1: |
| __NOTOC__ | | __NOTOC__ |
| *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| + | |
| | | |
| *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | | |
| *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| + | *'''[[Clinical guidelines and advice]]''' |
| | | |
− | ----
| |
| | | |
| | | |
− | *'''[[Structure of covid19]]''' | + | *'''[[Respiration mgmt]]''' |
− | {{tp|p=32361692|t=2020. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure |pdf=|usr=}}
| + | |
− | {{tp|p=32306836|t=2020. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment |pdf=|usr=}}
| + | |
| | | |
− | *'''[[Target binding and uptake]]''' | + | *'''[[Diagnosis (Laboratory)]]''' |
− | {{tp|p=32344526|t=2020. COVID-19 and RAS: Unravelling an Unclear Relationship |pdf=|usr=}}
| + | |
− | {{tp|p=32274964|t=2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin |pdf=|usr=}}
| + | |
| | | |
| | | |
− | *'''[[Cytopathic effects]]''' | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | | |
| + | *'''[[Diagnosis (other modalities)]]''' |
| + | |
| + | |
| + | |
| + | |
| + | *'''[[Structure of covid19]]''' |
| + | |
| + | |
| + | *'''[[Target binding and uptake]]''' |
| + | *'''[[Cytopathic effects]]''' |
| *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| + | |
| + | |
| | | |
| *'''[[Innate sensing]]''' | | *'''[[Innate sensing]]''' |
| | | |
| *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
− | {{tp|p=32360285|t=ä. Type I IFN immunoprofiling in COVID-19 patients |pdf=|usr=}}
| |
− | {{tp|p=32344056|t=ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination |pdf=|usr=}}
| |
− | {{tp|p=32333914|t=ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
− | {{tp|p=32334118|t=ä. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019 |pdf=|usr=}}
| |
− | {{tp|p=32360286|t=2020. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32311489|t=ä. Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection |pdf=|usr=}}
| |
| | | |
| | | |
| | | |
− | ----
| + | *'''[[Pathobiology]]''' |
| + | |
| + | |
| + | *'''[[Disease Models]]''' |
| + | |
| + | |
| + | *'''[[Similar diseases and pathomechanisms]]''' |
| + | |
| + | |
| | | |
| | | |
Zeile 46: |
Zeile 56: |
| *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| | | |
− | *'''[[ARDS]]'''
| |
| | | |
| *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
− | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| | | |
− | *'''[[Hematology]]'''
| |
| | | |
− | *'''[[Microvascular]]'''
| |
| | | |
− | *'''[[Heart]]'''
| |
| | | |
− | *'''[[Neurology, ophthalmology, orl]]'''
| |
− | {{tp|p=32251791|t=2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 |pdf=|usr=}}
| |
− | {{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}}
| |
− | {{tp|p=32332516|t=2020. Precaution and prevention of coronavirus disease 2019 infection in the eye |pdf=|usr=}}
| |
− | {{tp|p=32353982|t=2020. The Ocular Surface and the Coronavirus Disease 2019: Does a Dual Ocular Route Exist?|pdf=|usr=}}
| |
| | | |
| + | *'''[[Hematology]]''' |
| | | |
| | | |
− | *'''[[Dermatology]]'''
| |
| | | |
− | *'''[[Gastroenterology, hepatology]]''' | + | *'''[[Heart]]''' |
− | {{tp|p=32243269|t=2020. Gastrointestinal and liver manifestations in patients with COVID-19 |pdf=|usr=}}
| + | |
| | | |
− | *'''[[Kidney, urology]]'''
| |
| | | |
− | ----
| |
| | | |
| + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | |
− | *'''[[Pathobiology]]'''}
| |
− | {{tp|p=32357503|t=2020. COVID-19 Deaths: Are We Sure It Is Pneumonia? Please, Autopsy, Autopsy, Autopsy!|pdf=|usr=}}
| |
− | {{tp|p=32244779|t=2020. Master Regulator Analysis of the SARS-CoV-2/Human Interactome |pdf=|usr=}}
| |
| | | |
| | | |
− | *'''[[Disease Models]]''' | + | *'''[[Dermatology]]''' |
| | | |
− | *'''[[Similar diseases and pathomechanisms]]'''
| |
− | ----
| |
| | | |
| | | |
− | *'''[[Diagnosis (Laboratory)]]''' | + | *'''[[Gastroenterology, hepatology]]''' |
− | {{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
| + | |
− | {{tp|p=32286019|t=2020. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives |pdf=|usr=}}
| + | |
| | | |
| + | *'''[[Kidney, urology]]''' |
| | | |
− | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[The morbid survivor]]''' |
− | {{tp|p=32283052|t=ä. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis |pdf=|usr=}}
| + | |
− | {{tp|p=32236303|t=2020. COVID-19 pneumonia: what is the role of imaging in diagnosis?|pdf=|usr=}}
| + | |
− | {{tp|p=32321009|t=2020. COVID-19 pneumonia and the reversed halo sign |pdf=|usr=}}
| + | |
− | {{tp|p=32294718|t=2020. Presentation of pulmonary infection on CT in COVID-19: initial experience in Brazil |pdf=|usr=}}
| + | |
| | | |
− | *'''[[Diagnosis (other modalities)]]''' | + | *'''[[Risk and special populations]]''' |
− | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| + | |
| | | |
| | | |
− | *'''[[Respiration mgmt]]'''
| |
| | | |
− | *'''[[Clinical guidelines and advice]]''' | + | *'''[[Case reports]]''' |
| | | |
| | | |
− | *'''[[Risk and special populations]]'''
| |
− | {{tp|p=32370269|t=2020. Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?|pdf=|usr=}}
| |
− | {{tp|p=32244852|t=2020. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19) |pdf=|usr=}}
| |
| | | |
− | *'''[[The morbid survivor]]'''
| |
− | {{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
| |
| | | |
− | *'''[[Case reports]]'''
| |
− | {{tp|p=32269194|t=2020. Pneumonia Without Respiratory Symptoms |pdf=|usr=}}
| |
− | {{tp|p=32361703|t=2020. Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report |pdf=|usr=}}
| |
| | | |
| | | |
| | | |
| *'''[[Case series]]''' | | *'''[[Case series]]''' |
− | {{tp|p=32378815|t=2020. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Registries]]''' | | *'''[[Registries]]''' |
− | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
− |
| |
− |
| |
− | ----
| |
| | | |
| | | |
| *'''[[Trials]]''' | | *'''[[Trials]]''' |
− | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| | | |
| | | |
− | | + | *'''[[Other routes of infection]]''' |
− | ----
| + | |
| | | |
| | | |
| *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
− | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| | | |
− | *'''[[Other routes of infection]]'''
| |
− | {{tp|p=32335340|t=ä. Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health |pdf=|usr=}}
| |
− | {{tp|p=32278800|t=ä. Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?|pdf=|usr=}}
| |
| | | |
| | | |
| | | |
| + | *'''[[Passive protective equipment]]''' |
| | | |
− | *'''[[Remission, recurrence and persistence]]'''
| |
− | {{tp|p=32200109|t=2020. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge |pdf=|usr=}}
| |
− | {{tp|p=32251796|t=ä. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?|pdf=|usr=}}
| |
− | {{tp|p=32147538|t=2020. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report |pdf=|usr=}}
| |
− |
| |
− |
| |
− | *'''[[Passive protective equipment]]'''
| |
− | {{tp|p=32278727|t=ä. Ethical Rationing of Personal Protective Equipment to Minimize Moral Residue During the COVID-19 Pandemic |pdf=|usr=}}
| |
− | {{tp|p=32240303|t=ä. Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19 |pdf=|usr=}}
| |
− | {{tp|p=32353399|t=ä. Institution of a Novel Process for N95 Respirator Disinfection with Vaporized Hydrogen Peroxide in the setting of the COVID-19 Pandemic at a Large Academic Medical Center |pdf=|usr=}}
| |
− | {{tp|p=32370924|t=ä. Personal Protective Equipment: Current Best Practices for Orthopaedic Teams |pdf=|usr=}}
| |
− | {{tp|p=32354536|t=ä. Helmet Modification to PPE with 3D Printing During the COVID-19 Pandemic at Duke University Medical Center: A Novel Technique |pdf=|usr=}}
| |
| | | |
| | | |
| *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
− | ----
| |
| | | |
| | | |
| *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
− | {{tp|p=32259628|t=ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist |pdf=|usr=}}
| |
− | {{tp|p=32208139|t=ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness |pdf=|usr=}}
| |
| | | |
| + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | |
− |
| |
− | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
− | {{tp|p=32360185|t=ä. Exercise and Fitness in the age of social distancing during the COVID-19 Pandemic |pdf=|usr=}}
| |
− | {{tp|p=32078967|t=2020. Coronaphobia: Fear and the 2019-nCoV outbreak |pdf=|usr=}}
| |
− | {{tp|p=32333185|t=ä. Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic |pdf=|usr=}}
| |
− | {{tp|p=32331246|t=2020. Questionnaire on Perception of Threat from COVID-19 |pdf=|usr=}}
| |
| | | |
| | | |
| | | |
| *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
− | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | |
| | | |
| *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| + | |
| | | |
| *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
− | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
− | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
− | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
− |
| |
− |
| |
| | | |
| | | |
Zeile 202: |
Zeile 145: |
| | | |
| *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
− | {{tp|p=32212099|t=ä. COVID-19 may transmit through aerosol |pdf=|usr=}}
| |
| | | |
| *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
Zeile 209: |
Zeile 151: |
| | | |
| | | |
− | *'''[[Failure of politics and public health guidance]]''' | + | |
| + | |
| + | |
| + | *'''[[Remission, recurrence and persistence]]''' |
| + | |
| + | |
| | | |
| *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| ---- | | ---- |
| + | *'''[[Failure of politics and public health guidance]]''' |
| | | |
| | | |
| *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
− | {{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
| + | |
− | *[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
| + | |
| | | |
| | | |
| *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
− | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
− | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
− |
| |
| | | |
| *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| + | |
| ---- | | ---- |
| | | |
| | | |
| *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
− | {{tp|p=32120913|t=2020. Epidemiological Identification of A Novel Pathogen in Real Time: Analysis of the Atypical Pneumonia Outbreak in Wuhan, China, 2019?2020 |pdf=|usr=}}
| |
− |
| |
| *'''[[misc.]]''' | | *'''[[misc.]]''' |
− | {{tp|p=32343813|t=ä. Impact of the digital divide in the age of COVID-19 |pdf=|usr=}}
| + | |
− | {{tp|p=32313877|t=ä. COVID-19 Epidemic and Enhancing China?s National Biosecurity System |pdf=|usr=}}
| + | |
− | {{tp|p=32282413|t=ä. What?s Important: What Is Our Role in the COVID-19 Pandemic?|pdf=|usr=}}
| + | |
− | {{tp|p=32134861|t=2020. The outbreak of COVID-19: An overview |pdf=|usr=}}
| + | |
− | {{tp|p=32360509|t=ä. What evidence-based medicine researchers can do to help clinicians fighting COVID-2019?|pdf=|usr=}}
| + | |
− | {{tp|p=32330521|t=ä. COVID-19 research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine |pdf=|usr=}}
| + | |
− | {{tp|p=32325222|t=ä. Reply to letter to the editor ?Lessons from COVID-19 to Future Evidence Synthesis Efforts: First Living Search Strategy and Out of Date Scientific Publishing and Indexing Industry |pdf=|usr=}}
| + | |
− | {{tp|p=32330122|t=2020. Panic prescribing has become omnipresent during the COVID-19 pandemic |pdf=|usr=}}
| + | |
− | {{tp|p=32244415|t=2020. People with Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health Literacy |pdf=|usr=}}
| + | |
| | | |
| *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| + | |
| + | |
| + | |
| + | |
| + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| + | |
| + | |
| + | *'''[[PrePrint scene]]''' |
| + | |
| | | |
| *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
− | *[lifechemicals.com antiviral candidate drugs]
| + | |
− | *[biomol.com assays cytokines general spectrum]
| + | |
− | *
| + | |
− | TAO technical wear masken die recht rational aussehen
| + | |
| *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| + | *'''[[on-topic personal thoughts]]''' |